Sandor Victor
Transaction: 07/01/2026
BUY
Change
+152,207
Price
$7.85
Filing
07/06/2026
Type
BUY
AbCellera Biologics Inc.
ABCL • Biotechnology
$11.43
▼ -0.14 (-1.21%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$3.49B
Growth
23.2%
Cash Flow
2/5
Trend
Volatile
Evidence
Manageable debt level · 0.15Healthy liquidity · 11.32Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:01 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$11.43
Change-1.21%
Shares Out305.56M
Market Cap$3.49B
Enterprise Value$2.95B
52W Range2.75 - 8.44
Beta1.15
P/E-21.21
P/S52.78
P/B3.90
P/FCF-29.18
EV/Sales44.62
Price$11.43
Change-1.21%
Shares Out305.56M
Market Cap$3.49B
Enterprise Value$2.95B
52W Range2.75 - 8.44
Beta1.15
P/E-21.21
P/S52.78
P/B3.90
P/FCF-29.18
EV/Sales44.62
EV/EBITDA-16.65
EV/FCF-24.67
Earnings Yield-4.71%
FCF Yield-3.43%
Dividend Yield0.00%
Gross Margin61.64%
Oper. Margin-2.89%
Profit Margin-194.88%
Debt/Eq0.15
Current Ratio11.32
Quick Ratio11.23
Revenue 5Y23.18%
Target$15.33
Target Upside34.12%
Target Median$9.00
Target Range7.00 - 30.00
Volume8.06M
Avg Volume7.50M
EPS Surprise0.08
Investment DNA
How strong this company looks for long-term investors
44
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
47/100
Price Attractiveness
Cheap or expensive today
57/100
Why this score▼
Manageable debt level · 0.15Healthy liquidity · 11.32Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 12 analyst votes · 2026-09-05
96/100
Bullish
Bullish
11
Hold
1
Bearish
0
Price Target
2026-08-07
Low
$7.00
Mean
$8.00
Median
$8.00
High
$9.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Seely Lynn
Transaction: 07/01/2026
BUY
Change
+152,207
Price
$7.85
Filing
07/06/2026
Type
BUY
Seely Lynn
Transaction: 06/30/2026
OTHER
Change
0
Price
Not reported
Filing
07/06/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Sandor Victor | BUY | +152,207 | $7.85 | 07/01/2026 | 07/06/2026 |
| Seely Lynn | BUY | +152,207 | $7.85 | 07/01/2026 | 07/06/2026 |
| Seely Lynn | OTHER | 0 | Not reported | 06/30/2026 | 07/06/2026 |
| Montalbano John S. | BUY | +111,701 | $5.27 | 06/11/2026 | 06/12/2026 |
| Quake Stephen | BUY | +111,701 | $5.27 | 06/11/2026 | 06/12/2026 |
| Hayden Michael R | BUY | +111,701 | $5.27 | 06/11/2026 | 06/12/2026 |
| Sandor Victor | OTHER | 0 | Not reported | 06/01/2026 | 06/11/2026 |
| Montalbano John S. | BUY | +20,000 | $4.77 | 05/14/2026 | 05/18/2026 |
| Thermopylae Holdings Ltd. | BUY | +38,000 | $3.44 | 02/27/2026 | 03/02/2026 |
| Booth Andrew | BUY | +42,600 | $3.42 | 02/27/2026 | 02/27/2026 |
| Thermopylae Holdings Ltd. | BUY | +177,457 | $3.27 | 02/26/2026 | 02/27/2026 |
| Lecault Veronique | BUY | +539,265 | $3.42 | 01/01/2026 | 01/05/2026 |
| Stimart Tryn | BUY | +539,265 | $3.42 | 01/01/2026 | 01/05/2026 |
| Hansen Carl L. G. | BUY | +2,106,505 | $3.42 | 01/01/2026 | 01/05/2026 |
| Booth Andrew | BUY | +808,898 | $3.42 | 01/01/2026 | 01/05/2026 |
| Thermopylae Holdings Ltd. | SELL | -225,000 | Not reported | 12/18/2025 | 12/19/2025 |
| Quake Stephen | BUY | +194,932 | $3.47 | 12/01/2025 | 12/19/2025 |
| Quake Stephen | OTHER | 0 | Not reported | 11/10/2025 | 12/19/2025 |
| Montalbano John S. | BUY | +50,000 | $3.57 | 11/26/2025 | 11/26/2025 |
| Hayden Michael R | BUY | +238,864 | $3.15 | 06/12/2025 | 07/01/2025 |